 |
   |
 |
  |
 |
 |
 |
 |
 |
|
|
||||||
|
|
||||||
|
|
|||||||
Am J Cardiol
Am J Cardiovasc Drugs
Am J Rhinol
Arch Neurol
Arch Ophthalmol
Br J Clin Pharmacol
Br J Urol International
Clin Drug Invest
Clin Pharmacol Ther
Clin Ther
Curr Med Res Opinion
Diabetes Care
Diabetes Obes Metab
Drugs of the Future
Drug Safety
Eur J Endocrinol
Eur Heart J
Eur Urol
Int J Clin Pract
J Urol
Mayo Clin Proc
Nutr Metab Cardiovasc Dis
N-Acetylcysteine
Atypical antipsychotic
Bisphosphonates
Centrally acting skeletal muscle relaxant
Endothelin receptor antagonists
Glycoprotein IIb/IIIa receptor antagonists
HMG-CoA reductase inhibitors (statins)
Incretin enhancer (DPP-IV inhibitor)
Incretin mimetics
Insulin pen
MK-0524 (laropiprant)
Oral second-generation H1 antihistamine
Phosphodiesterase type 5 inhibitors
Recombinant Human Activated Protein C
Selective norepinephrine reuptake inhibitor (for ADHD)
Selective serotonin/norepinephrine reuptake inhibitor
Topical second-generation H1 antihistamine